The Immunohematology Market is expected to witness significant growth due to increasing prevalence of blood disorders and rising demand for blood transfusions. Technological advancements in the field of immunohematology are also driving market growth by improving accuracy and efficiency of blood testing procedures. Additionally, growing awareness about blood group typing and cross-matching for safe transfusions is fueling market expansion.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Technology, End-User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Grifols S.A., Immucor, Thermo Fisher Scientific, Merck KGaA, Abbott Laboratories, . |
The Immunohematology Market is faced with challenges such as high costs associated with advanced blood testing equipment and reagents. Limited availability of skilled professionals trained in immunohematology techniques is also hindering market growth. This shortage of trained personnel is leading to delays in blood testing procedures and impacting overall efficiency in blood banking systems.